<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li T</submitter><funding>Doctoral Fund of Jining No.1 People's Hospital</funding><funding>Projects of medical and health technology development program in Shandong province</funding><funding>Natural Science Research Project of Universities in Jiangsu Province</funding><funding>Key Research and Development Program of Jining Science and Technology</funding><funding>General Program of China Postdoctoral Science Foundation</funding><funding>Suzhou Science and Technology Council</funding><funding>Natural Science Foundation of Jiangsu Province</funding><pagination>e2307648</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10870076</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(7)</volume><pubmed_abstract>T-2 toxin causes renal dysfunction with proteinuria and glomerular podocyte damage. This work explores the role of metabolic disorder/reprogramming-mediated epigenetic modification in the progression of T-2 toxin-stimulated podocyte injury. A metabolomics experiment is performed to assess metabolic responses to T-2 toxin infection in human podocytes. Roles of protein O-linked-N-acetylglucosaminylation (O-GlcNAcylation) in regulating T-2 toxin-stimulated podocyte injury in mouse and podocyte models are assessed. O-GlcNAc target proteins are recognized by mass spectrometry and co-immunoprecipitation experiments. Moreover, histone acetylation and autophagy levels are measured. T-2 toxin infection upregulates glucose transporter type 1 (GLUT1) expression and enhances hexosamine biosynthetic pa</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>T-2 Toxin-Mediated β-Arrestin-1 O-GlcNAcylation Exacerbates Glomerular Podocyte Injury via Regulating Histone Acetylation.</pubmed_title><pmcid>PMC10870076</pmcid><funding_grant_id>2022M711369</funding_grant_id><funding_grant_id>BK20221091</funding_grant_id><funding_grant_id>2022YXNS118</funding_grant_id><funding_grant_id>2021-BS-008</funding_grant_id><funding_grant_id>SNG201907</funding_grant_id><funding_grant_id>20KJB330002</funding_grant_id><funding_grant_id>202113050502</funding_grant_id><pubmed_authors>He C</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Chang T</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Sun W</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>T-2 Toxin-Mediated β-Arrestin-1 O-GlcNAcylation Exacerbates Glomerular Podocyte Injury via Regulating Histone Acetylation.</name><description>T-2 toxin causes renal dysfunction with proteinuria and glomerular podocyte damage. This work explores the role of metabolic disorder/reprogramming-mediated epigenetic modification in the progression of T-2 toxin-stimulated podocyte injury. A metabolomics experiment is performed to assess metabolic responses to T-2 toxin infection in human podocytes. Roles of protein O-linked-N-acetylglucosaminylation (O-GlcNAcylation) in regulating T-2 toxin-stimulated podocyte injury in mouse and podocyte models are assessed. O-GlcNAc target proteins are recognized by mass spectrometry and co-immunoprecipitation experiments. Moreover, histone acetylation and autophagy levels are measured. T-2 toxin infection upregulates glucose transporter type 1 (GLUT1) expression and enhances hexosamine biosynthetic pa</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-12T05:50:40.007Z</modification><creation>2025-04-05T09:07:16.008Z</creation></dates><accession>S-EPMC10870076</accession><cross_references><pubmed>38083975</pubmed><doi>10.1002/advs.202307648</doi></cross_references></HashMap>